Company Profile

About us

CorTAG is committed to the development, validation and application of groundbreaking methods in the field of cardiogenetic diagnostics. These methods are extremely useful for the detection of genetic defects (referred to as "mutations") that underly a range of different, partially overlapping cardiovascular conditions such as Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Long QT Syndrome and Marfan Syndrome